financetom
Business
financetom
/
Business
/
Gilat Satellite Networks Q3 Adjusted Earnings, Revenue Rise; 2025 Revenue Outlook Narrowed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gilat Satellite Networks Q3 Adjusted Earnings, Revenue Rise; 2025 Revenue Outlook Narrowed
Nov 12, 2025 5:13 AM

07:47 AM EST, 11/12/2025 (MT Newswires) -- Gilat Satellite Networks ( GILT ) reported Q3 adjusted earnings Wednesday of $0.19 per diluted share, up from $0.14 a year earlier.

Four analysts surveyed by FactSet expected $0.10.

Revenue for the quarter ended Sept. 30 was $117.7 million, up from $74.6 million a year earlier.

Four analysts polled by FactSet expected $113.2 million.

The company narrowed its 2025 revenue guidance to now be between $445 million and $455 million, compared with its previous outlook range of between $435 million and $455 million.

Four analysts surveyed by FactSet expect $440.7 million.

Shares of the company were up over 5% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guardant Health Q2 revenue beats estimates
Guardant Health Q2 revenue beats estimates
Jul 30, 2025
Overview * Guardant Health Q2 2025 revenue rises 31%, beating analyst expectations, per LSEG data * The precision medicine company focused on improving cancer raises 2025 revenue guidance to $915-$925 mln Outlook * Guardant Health ( GH ) raises 2025 revenue guidance to $915-$925 mln * Company expects 2025 oncology revenue to grow 20% year-over-year * Screening revenue now expected...
SAGE Therapeutics Q2 revenue rises sequentially 
SAGE Therapeutics Q2 revenue rises sequentially 
Jul 30, 2025
Overview * SAGE Therapeutics Q2 collaboration revenue from ZURZUVAE rises 68% from Q1 2025 * Company's acquisition by Supernus Pharmaceuticals expected to close in Q3 2025 * Net loss for Q2 2025 was $49.7 mln, cash position at $366 mln Outlook * Company anticipates investments will help topline revenue growth in 2025 * SAGE-319 Phase 1 study data expected by...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Albemarle posts surprise second-quarter profit
Albemarle posts surprise second-quarter profit
Jul 30, 2025
July 30 (Reuters) - Albemarle, the world's largest producer of lithium for rechargeable batteries, posted a surprise second-quarter profit on Wednesday, helped by rising demand for the metal. The Charlotte, North Carolina-based company reported an adjusted profit of 11 cents per share, compared with analysts' expectations of 82 cents loss per share, according to data compiled by LSEG. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved